Adjuvant effect of vitamin C on omeprazole-amoxicillin-clarithromycin triple therapy for Helicobacter pylori eradication

Hepato-Gastroenterology

Volumn 54, Issue 73, 2007, Pages 320-324

  Chuang, Chiao Hsiung ^a   Sheu, Bor Shyang ^a,c   Kao, Ai Wen ^a   Cheng, Hsiu Chi ^a   Huang, Ay Huey ^a   Yang, Hsiao Bai ^a,b   Wu, Jiunn Jong ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b Ton Yen General Hospital   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Clarithromycin; Eradication; Helicobacter pylori; Vitamin C

Indexed keywords

AMOXICILLIN; ASCORBIC ACID; CARBON 13; CLARITHROMYCIN; OMEPRAZOLE;

ADJUVANT THERAPY; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; UREA BREATH TEST;

ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; ASCORBIC ACID; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; DUODENAL ULCER; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROTON PUMPS; STOMACH ULCER;

EID: 34047116251     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Malfertheiner P, Megraud F, O'Morain C, et al: Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus report. Aliment Pharmacol Ther 2002; 16:167-180.
2. Bazzoli F, Pozzato P, Rokkas T: Helicobacter pylori: the challenge in therapy. Helicobacter 2002; 7(Suppl 1):43-49.
3. Yukselen V, Yasa MH, Karaoglu AO: In treatment of active duodenal ulcer and Helicobacter pylori eradication. Hepatogastroenterology 2003; 50(Suppl 2):cccvi-cccviii.
4. Danese S, Armuzzi A, Romano A: Efficacy and tolerability of antibiotics in patients undergoing H. pylori eradication. Hepatogastroenterology 2001; 48:465-467.
5. Katelaris PH, Forbes GM, Talley NJ, Crotty B: A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE study. Gastroenterology 2002; 123:1763-179.
6. Lind T, Megraud F, Unge P, et al: The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with one-week triple therapies. Gastroenterology 1999; 116:248-253.
7. Perri F, Qasim A, Marras L, O'Morain C: Treatment of Helicobacter pylori infection. Helicobacter 2003; 8(Suppl 1):53-60.
8. Halliwell B, Gutteridge JMC, Cross CE: Free radicals, antioxidants and human disease: where are we now? J Lab Clin Med 1992; 119:598-620.
9. Cohen M, Bhagavan UN: Ascorbic acid and gastrointestinal cancer. J am Coll Nutr 1995; 14:565-578.
10. Drake IM, Davies MJ, Mapstone NP, et al: Ascorbic acid may protect against human gastric cancer by scavenging mucosal oxygen radicals. Carcinogenesis 1996; 17:559-562.
11. Capurso G, Ricci R, Panzuto F, et al: Intragastric ascorbic but not uric acid is depleted in relation with the increased pH in patients with atrophic body gastritis and H. pylori gastritis. Helicobacter 2003; 8:300-306.
12. Phull PS, Price AB, Thormiley MS, Green CJ, Jacyna MR: Vitamin E concentrations in the human stomach and duodenum - correlation with Helicobacter pylori infection. Gut 1996; 39:31-35.
13. Zhang Zw, Patchett SE, Perrett D, Katelaris PH, Domizio P, Farthing MJG: The relation between gastric vitamin C concentrations, mucosal histology, and CagA seropositivity in the human stomach. Gut 1998; 43:322-326.
14. Sobala GM, Schorah C J, Shires S, et al: Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations. Gut 1993; 34:1038-1041.
15. Zhang HM, Wakisaka N, Maeda O, Yamamoto T: Vitamin C inhibits the growth of a bacterial risk factor for gastric carcinoma: Helicobacter pylori. Cancer 1997; 80:1897-902.
16. Tabak M, ArmonR, Rosenblat G, Stermer E, Neeman I: Diverse effects of ascorbic acid and palmitoyl ascorbate on Helicobacter pylori survival and growth. FEMS Microbiol Lett 2003; 224:247-253.
17. Sjunnesson H, Sturegard E, Willen R, Wadstrom T: High intake of selenium, beta-carotene, and vitamins A, C, and E reduces growth of Helicobacter pylori in the guinea pig. Comp Med 2001; 51:418-423.
18. Wang X, Aleljung P, Willen R, Wadström T: Effects of an tioxidants against H. pylori infection in BALB/cA mice. Gut 1998; 43(Suppl):A32.
19. 13C-urea breath test is mandatory to detect H. pylori infection of patients after proton pump inhibitor-based triple therapy. Dig Dis Sci 2000; 45:1330-1336.
20. Yang HB, Sheu BS, Su IJ, Chien CH, Lin XZ: Clinical application of gastric histology to monitor treatment of dual therapy in H. pylori eradication. Dig Dis Sci 1997; 42:1835-1840.
21. Sheu BS, Sheu SM, Yang HB, Huang AH, Wu JJ: Host gastric Lewis expressions determine the bacterial density of Helicobacter pylori in babA2-genopositive infection. Gut 2003; 52:927-932.
22. Chi CH, Lin CY, Sheu BS, Yang HB, Huang AH, Wu JJ: Quadruple therapy containing amoxicillin and tetracycline is an effective regimen to rescue failed triple therapy by overcoming the antimicrobial resistance of Helicobacter pylori. Aliment Pharmacol Ther 2003; 18:347-353.
23. Chuang CH, Sheu BS, Huang AH, Yang HB, Wu JJ: Vitamin C and E supplement to lansoprazole-amoxicillin-metronidazole triple therapy may reduce the eradication rate of metronidazole susceptible Helicobacter pylori infection. Helicobacter 2002; 7:310-316.
24. Kockar C, Ozturk M, Bavbek N: Helicobacter pylori eradication with beta carotene, ascorbic acid and allicin. Acta Medica 2001; 44:97-100.
25. Jarosz M, Dzieniszewski J, Dabrowska-Ufniarz E: Eradication of H. pylori using one-week therapy combining PPI with antibiotics and vitamin C. Gut 2001; 49(Suppl II):A69.
26. Jarosz M, Dzieniszewski J, Dabrowska-Ufniarz E, Wartanowicz M, Ziemlanski S, Reed PI: Effects of high dose vitamin C treatment on Helicobacter pylori infection and total vitamin C concentration in gastric juice. Eur J Cancer Prev 1998; 7:449-454.
27. Euopean Helicobacter pylori Study Group: Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997; 41:8-13.
28. Choi IJ, Jung HC, Choi KW, et al: Efficacy of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 2002; 16:145-151.
29. Gisbert JP, Gonzalez L, Calvet X, et al: Proton pump inhibitor, clarithromycin and either amoxicillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori. Aliment Pharmacol Ther 2000; 14:1319-1328.
30. Huang J, Hunt RH: The importance of clarithiomycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxicillin or metronidazole. Aliment Pharmacol Ther 1999; 13:719-29.